New research shows another experimental Alzheimer s drug can modestly slow patients inevitable worsening. Patients given monthly infusions of Eli Lilly and Co. s donanemab declined about four to seven months more
WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Second Alzheimer s drug in the pipeline promises to slow worsening but with safety concern – Metro US metro.us - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metro.us Daily Mail and Mail on Sunday newspapers.
Second Alzheimer s drug in the pipeline promises to slow worsening but with safety concern sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.